Allen Lutz
Stock Analyst at Bank of America Securities
(4.72)
# 689
Out of 4,996 analysts
623
Total ratings
64%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintained: Buy | $11 | $6.24 | +68.40% | 82 | Sep 24, 2026 | |
| DOCS Doximity | Reiterated: Sell | $20 | $26.57 | -24.73% | 46 | Sep 23, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,050 | $880.50 | +19.25% | 41 | Sep 16, 2026 | |
| CVS CVS Health | Reiterated: Buy | $120 | $85.72 | +39.99% | 35 | Sep 15, 2026 | |
| GDRX GoodRx Holdings | Reiterated: Sell | $2.65 | $3.32 | -20.18% | 32 | Sep 15, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $32 | $27.80 | +15.11% | 76 | Sep 15, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $34 | $23.82 | +42.74% | 24 | Sep 15, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $38 | $25.10 | +51.39% | 25 | Sep 15, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $95 → $110 | $84.47 | +30.22% | 24 | Sep 10, 2026 | |
| GRDN Guardian Pharmacy Services | Reiterated: Buy | $47 | $43.11 | +9.02% | 7 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $90.39 | +38.29% | 58 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $312.28 | +5.67% | 26 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 → $1.3 | $0.75 | +73.33% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.7 | $1.01 | -30.69% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $25.67 | +20.76% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.07 | - | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $221.73 | +17.26% | 21 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.75 | +74.36% | 23 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.34 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $5.21 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
Teladoc Health
Sep 24, 2026
Maintained: Buy
Price Target: $11
Current: $6.24
Upside: +68.40%
Doximity
Sep 23, 2026
Reiterated: Sell
Price Target: $20
Current: $26.57
Upside: -24.73%
McKesson
Sep 16, 2026
Reiterated: Buy
Price Target: $1,050
Current: $880.50
Upside: +19.25%
CVS Health
Sep 15, 2026
Reiterated: Buy
Price Target: $120
Current: $85.72
Upside: +39.99%
GoodRx Holdings
Sep 15, 2026
Reiterated: Sell
Price Target: $2.65
Current: $3.32
Upside: -20.18%
Hims & Hers Health
Sep 15, 2026
Reiterated: Hold
Price Target: $32
Current: $27.80
Upside: +15.11%
Envista Holdings
Sep 15, 2026
Reiterated: Buy
Price Target: $34
Current: $23.82
Upside: +42.74%
Waystar Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $38
Current: $25.10
Upside: +51.39%
Henry Schein
Sep 10, 2026
Reiterated: Buy
Price Target: $95 → $110
Current: $84.47
Upside: +30.22%
Guardian Pharmacy Services
Sep 1, 2026
Reiterated: Buy
Price Target: $47
Current: $43.11
Upside: +9.02%
Aug 28, 2026
Reiterated: Buy
Price Target: $125
Current: $90.39
Upside: +38.29%
Aug 12, 2026
Reiterated: Hold
Price Target: $330
Current: $312.28
Upside: +5.67%
Aug 11, 2026
Reiterated: Sell
Price Target: $2.25 → $1.3
Current: $0.75
Upside: +73.33%
Aug 11, 2026
Reiterated: Sell
Price Target: $0.7
Current: $1.01
Upside: -30.69%
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $25.67
Upside: +20.76%
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.07
Upside: -
Jul 20, 2026
Reiterated: Buy
Price Target: $260
Current: $221.73
Upside: +17.26%
Jun 11, 2026
Reiterated: Buy
Price Target: $17
Current: $9.75
Upside: +74.36%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $13.34
Upside: n/a
Jun 20, 2023
Reiterated: Hold
Price Target: $12
Current: $5.21
Upside: n/a
Aug 10, 2022
Reiterated: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a